Cyclophosphamide and fludarabine monophosphate dose optimization for the non-myeloablative condition in non-human primates to induce transient mixed chimerism via bone marrow transplantation

Bone marrow preconditioning using cyclophosphamide (CP) is generally used for bone marrow transplantation (BMT). However, because of CP’s hepatotoxicity and nephrotoxicity, additional fludarabine (FDR) administration and a reduced dose of CP are used for reduced-intensity preconditioning. Recently,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Transl Res
Glavni autori: Kwon, Yeongbeen, Lee, Kyo Won, Park, Hyojun, Son, Jin Kyung, Lee, JongHyun, Cho, Chan Woo, Kwon, Ghee Young, Park, Jae Berm, Kim, Sung Joo
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834517/
https://ncbi.nlm.nih.gov/pubmed/31737196
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items